Author

N. Ikemura

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Bioengineering· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:chromatin & epigenetic regulation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Hoshino· 4 shared D. Motooka· 4 shared S. Matoba· 4 shared Y. Kirita· 4 shared J. Takagi· 3 shared S. Taminishi· 3 shared T. Arimori· 3 shared T. Okamoto· 3 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

A. Hoshino

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Fibroblast Nrf2 inhibits profibrotic transcription with Ddx54 and mitigates pathological fibrosis in the mouse heart and kidney

A. Hoshino, T. Nishiji, N. Ikemura, M. C. Alcantara, Y. Higuchi, Y. Uchio, Y. Kirita, S. Taminishi, Y. Ozaki, D. Motooka, R. Kobayashi, T. Horii, I. Hatada, S. Matoba

This study identifies the Keap1-Nrf2 pathway as a regulator of TGF-β-mediated CTGF expression in fibroblasts, showing that Nrf2 with Ddx54 suppresses profibrotic genes and reduces fibrosis in mouse heart and kidney.

bioRxiv · Nov 9, 2023 · PreprintCell Biology

Deep mutational scanning of whole SARS-CoV-2 spike in an inverted infection system

S. Taminishi, S. Li, Y. Higuchi, Y. Kirita, D. Motooka, Y. Ozaki, T. Arimori, N. Ikemura, Y. Ito, S. Matoba, T. Okamoto, J. Takagi, D. M. Standley, A. Hoshino

The paper develops a DMS platform to analyze SARS-CoV-2 spike mutations, finding that spike expression, not ACE2 affinity, primarily affects infectivity and evolution.

bioRxiv · Jul 17, 2023 · PreprintMicrobiology

Engineered ACE2 counteracts vaccine-evading SARS-CoV-2 Omicron variant

N. Ikemura, S. Taminishi, T. Inaba, T. Arimori, D. Motooka, K. Katoh, Y. Kirita, Y. Kirita, S. Li, T. Suzuki, Y. Itoh, Y. Ozaki, S. Nakamura, S. Matoba, D. M. Standley, , A. Hoshino

This paper shows engineered ACE2 neutralizes Omicron and other sarbecoviruses effectively despite its high number of spike mutations.

bioRxiv · Dec 22, 2021 · PreprintMicrobiology

High affinity modified ACE2 receptors protect from SARS-CoV-2 infection in hamsters

Y. Higuchi, T. Suzuki, T. Arimori, N. Ikemura, Y. Kirita, E. Ohgitani, O. Mazda, D. Motooka, S. Nakamura, Y. Sakai, Y. Itoh, F. Sugihara, Y. Matsuura, S. Matoba, T. Okamoto, , A. Hoshino

The paper engineers high-affinity ACE2 receptors to neutralize SARS-CoV-2 in hamsters, showing protection against infection without viral escape mutations.

bioRxiv · Sep 16, 2020 · PreprintBioengineering